FibroBiologics, Inc.
FBLG
DELAYED 1 MONTH

7 insider filings · Latest: May 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 4, 2026Mar 5 1:00 PMHamid KhojaChief Scientific Officer
Purchase
30,000$0.38$11.4K61,250(D)

View →

Mar 4, 2026Mar 4 10:50 PMO'HEERON PETEDirector, CHIEF EXECUTIVE OFFICER
Purchase
15,872$0.3784$6.0K5,958,147(D)

View →

Mar 3, 2026Mar 4 10:50 PMO'HEERON PETEDirector, CHIEF EXECUTIVE OFFICER
Purchase
18,200$0.4051$7.4K5,942,275(D)

View →

Mar 2, 2026Mar 4 10:50 PMO'HEERON PETEDirector, CHIEF EXECUTIVE OFFICER
Purchase
17,428$0.353$6.2K5,924,075(D)

View →

Mar 2, 2026Mar 3 1:00 PMJason DavisChief Financial Officer
Purchase
70,000$0.4139$29.0K70,000(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 4, 2026May 4 11:01 PMO'HEERON PETEDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
92,410$1.3892,410(D)

View →

May 4, 2026May 4 11:00 PMHamid KhojaChief Scientific Officer
Grant/Award
61,607$1.3861,607(D)

View →

May 4, 2026May 4 11:00 PMJason DavisChief Financial Officer
Grant/Award
61,607$1.3861,607(D)

View →

May 4, 2026May 4 11:00 PMRuben A GarciaGeneral Counsel
Grant/Award
61,607$1.3861,607(D)

View →